Ariadne Wealth Management, LP
Source: SEC Form 13F · as of Mar 2026Ariadne Wealth Management, LP holds 13 biotech & pharma companies tracked by BioSniper, totaling $8.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$8.6M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 1,234 | $1.1M |
| ABBVAbbVie Inc. | 4,667 | $1.0M |
| BMYBRISTOL MYERS SQUIBB CO | 16,357 | $992K |
| GMOptec International, Inc. | 11,861 | $884K |
| JNJJOHNSON & JOHNSON | 3,373 | $824K |
| NVSNovartis AG | 5,319 | $812K |
| MRKMerck & Co., Inc. | 6,558 | $794K |
| GILDGILEAD SCIENCES, INC. | 5,675 | $791K |
| PMPhilip Morris International Inc | 2,726 | $455K |
| INCYIncyte Corp. | 3,871 | $364K |
| UTHRUNITED THERAPEUTICS Corp | 441 | $262K |
| MEDPMedpace Holdings Inc. | 438 | $210K |
| IRWDIRONWOOD PHARMACEUTICALS INC | 12,564 | $44K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.